about
Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancerParallel visualization of multiple protein complexes in individual cells in tumor tissueCytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosisPerspectives on the chemical etiology of breast cancer.Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data.First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?Targeted Therapies in HER2-Positive Breast Cancer - a Systematic ReviewGene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathwaysConcerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/NeuHER2 testing: a review of detection methodologies and their clinical performanceColony-stimulating factor 1 promotes progression of mammary tumors to malignancyOvercoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.Profiling the HER3/PI3K pathway in breast tumors using proximity-directed assays identifies correlations between protein complexes and phosphoproteins.Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer.Plasmonic Nanoparticles and Nanowires: Design, Fabrication and Application in SensingMultiplex detection of breast cancer biomarkers using plasmonic molecular sentinel nanoprobesDegradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells.A systematic analysis of miRNA-mRNA paired variations reveals widespread miRNA misregulation in breast cancer.Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growthIdentification of a novel luminal molecular subtype of breast cancer.Low Level of Her-2 Locus Amplification by Fluorescent In Situ Hybridization Does Not Correlate with Her-2 Protein Overexpression by Immunohistochemistry in Barrett's Esophagus.Drug delivery to brain tumours: challenges and progress.Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.HER2/neu antisense targeting of human breast carcinoma.Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic ImplicationsBiologic and therapeutic role of HER2 in cancer.Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA studyCancer genetics and tumor antigens: time for a combined view?Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.Overexpression of Eag1 potassium channels in clinical tumours.HER2 gene and protein expression status of breast carcinoma can be reliably tested on a single slideNF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis.Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study.CD4(+) T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8(+) T-cell Targeting of HER2/neu-Expressing CancersSingle cell analysis of cancer cells using an improved RT-MLPA method has potential for cancer diagnosis and monitoring.Interactions of tumour-derived micro(nano)vesicles with human gastric cancer cells.
P2860
Q24301665-E4F26761-1BFA-4FF7-BE02-BFE546B3B1AAQ24320208-9EC8B9F1-0650-42DA-9FAA-CAA3527622FAQ24802985-8C61BA67-B753-4630-8670-FB48F14CC2A3Q24811790-AB1820E6-7D6A-4AB6-AB0B-FCA92F535705Q24817218-5ADD72D6-8847-4325-AE67-908F00A65CA3Q26746081-0B95AF95-C684-477A-9CF5-5F53840FAAE6Q26777733-06B7C784-3686-4B5A-8CD0-5095E53758B0Q26821895-6481793B-BB52-4681-A33C-F49BA97A5503Q28241103-0C65E73B-3B51-40C1-9360-7978BE15E55AQ28280488-35EB8E75-9BF3-48C2-A225-FBB2D64F65F4Q29614312-B5235C66-47B5-4D5F-A956-A9FC6EE34470Q30544833-44A942E9-B448-437F-A8DF-A0E86F3FD89FQ30997919-C81A916E-71E3-4F7C-8172-6B9DB16E0DCBQ31129446-9C9167C2-B4F8-4BA7-8BFD-354E1E24A8B2Q33557258-7476D1D3-BFE8-479D-AA01-9827D23DBD8AQ33616961-4D077791-CF13-4491-AE5A-80A3DA836B13Q33616968-9470EDE2-24ED-40BE-9292-2833AEB6F127Q33637919-581D6D45-45CF-4A30-B1E3-2CE62BCBF7E6Q33737607-5F2B94BB-ED02-49D0-8CEF-9A8248FF5DBBQ33911239-62FA1E11-8ABC-4E1F-8662-561A29E81D15Q33975444-B5541DAB-C09C-430A-98EB-88895CB1AEF0Q33984756-6373FA19-70AC-4A10-8E47-2BCABF31D945Q33997439-6FA25AF8-65D3-4A16-9D34-FA883956EDA9Q34001014-E59F03BB-DBB1-4501-B72A-19A1AA548BDFQ34020681-268423F6-2455-4719-B011-83B624B8DE7AQ34130563-06333B8D-EFDF-417C-9C60-6DB3FFFAE215Q34223494-64968B44-E87B-4344-9C3C-21921EAD91FDQ34267775-915AEAA7-2943-4B8B-A984-017EB636D523Q34272277-4AD7F997-3D5E-4BDE-847E-B3B2ECC2A0CFQ34347517-ECFF4052-F806-465C-BA06-633352E79F33Q34485373-F7346DC1-1EE1-40A0-9E5B-2EEE831A2ADDQ34495646-3820A4F3-89FE-4C4D-9295-AE617CA74C11Q34939322-B03EFB7E-23AE-4425-AF4F-759B6AB06948Q35107467-CE6B73AD-85BB-4D75-957C-458C0183F61BQ35929360-70E9B37F-DFF3-4B2D-B4C5-B2BA96C16EFAQ35971557-0080FFEB-B7E4-456D-9581-1F58829AD4BFQ35997942-857A9B43-7197-475D-A25E-D5FCE6D9904EQ36015421-B22ADA2B-1F87-49D8-AAD2-65F758D67EABQ36272624-BF8FF448-24AA-42EE-8122-4C4474641B4CQ36337082-60D484B3-DD8A-4987-82FB-2F2056E5C75D
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Role of HER2 gene overexpression in breast carcinoma.
@ast
Role of HER2 gene overexpression in breast carcinoma.
@en
type
label
Role of HER2 gene overexpression in breast carcinoma.
@ast
Role of HER2 gene overexpression in breast carcinoma.
@en
prefLabel
Role of HER2 gene overexpression in breast carcinoma.
@ast
Role of HER2 gene overexpression in breast carcinoma.
@en
P2093
P2860
P1476
Role of HER2 gene overexpression in breast carcinoma.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E
P577
2000-02-01T00:00:00Z